Physician profile
Scott M Benjamin
NPI 1124025564
$2,084.44
in general payments reported to CMS, 2019-2025
18 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.02 · 2020: $66.43 · 2021: $29.78 · 2022: $1,200 · 2023: $80.83 · 2024: $401 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $210.66 | 2019-2025 | Oasis, Stravix, Collagenase Santyl |
| Stryker Corporation | $194.67 | 2024-2025 | Prostep, Easyfuse, 7 X 23mm Citrelock Implant |
| Kerecis Limited | $75.26 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Averitas Pharma INC. | $59.39 | 2024-2025 | Qutenza |
| Mf Med | $40.55 | 2025 | |
| Depuy Synthes Sales INC. | $37.88 | 2025 | Motoband |
| Vertex Pharmaceuticals Incorporated | $37.12 | 2025 | |
| Organogenesis INC. | $35.21 | 2019-2020 | |
| Convatec INC. | $34.34 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $31.25 | 2024 | Exparel |
| Paratek Pharmaceuticals, INC. | $28.07 | 2020 | |
| Amgen INC. | $20.12 | 2024 | Evenity, Prolia |
| Solventum Corporation | $19.57 | 2024 | Prevena |
| Ibsa Pharma INC. | $16.60 | 2024 | Licart, Tirosint |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $14.77 | 2019 | |
| Tactile Systems Technology INC | $14.60 | 2024 | Flexitouch Plus, Entre Plus |
| Glaxosmithkline, LLC. | $14.38 | 2023 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.